Mara Farcasanu1,2,3, Douglas S Kwon4,5,6. 1. Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, 400 Technology Square, Cambridge, MA, 02139, USA. 2. Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, 02115, USA. 3. Harvard Medical School, Boston, MA, 02115, USA. 4. Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, 400 Technology Square, Cambridge, MA, 02139, USA. dkwon@mgh.harvard.edu. 5. Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, 02115, USA. dkwon@mgh.harvard.edu. 6. Harvard Medical School, Boston, MA, 02115, USA. dkwon@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: Young women in sub-Saharan Africa bear a disproportionate burden of the global HIV epidemic. In this review, we examine how cervicovaginal microbiota modulate structural and immune defenses in the female genital tract and influence HIV susceptibility. RECENT FINDINGS: Highly diverse, anaerobic cervicovaginal microbiota prevalent in sub-Saharan African women increase HIV acquisition risk by over fourfold. These bacteria weaken the barrier properties of the vaginal mucosa and increase local inflammation and HIV target cell recruitment, creating an environment permissive to HIV. These communities also diminish the prophylactic efficacy of topical tenofovir and therefore may modulate both biological susceptibility to HIV and the effectiveness of pre-exposure prophylaxis (PrEP). Cervicovaginal bacteria influence multiple reproductive health outcomes, including HIV acquisition. High-diversity, low Lactobacillus abundance cervicovaginal communities prevalent in many regions with high HIV incidence are associated with increased HIV susceptibility. A better understanding of the host-microbial interactions mediating this risk is important to reduce HIV infections, particularly among women living in sub-Saharan Africa.
PURPOSE OF REVIEW: Young women in sub-Saharan Africa bear a disproportionate burden of the global HIV epidemic. In this review, we examine how cervicovaginal microbiota modulate structural and immune defenses in the female genital tract and influence HIV susceptibility. RECENT FINDINGS: Highly diverse, anaerobic cervicovaginal microbiota prevalent in sub-Saharan African women increase HIV acquisition risk by over fourfold. These bacteria weaken the barrier properties of the vaginal mucosa and increase local inflammation and HIV target cell recruitment, creating an environment permissive to HIV. These communities also diminish the prophylactic efficacy of topical tenofovir and therefore may modulate both biological susceptibility to HIV and the effectiveness of pre-exposure prophylaxis (PrEP). Cervicovaginal bacteria influence multiple reproductive health outcomes, including HIV acquisition. High-diversity, low Lactobacillus abundance cervicovaginal communities prevalent in many regions with high HIV incidence are associated with increased HIV susceptibility. A better understanding of the host-microbial interactions mediating this risk is important to reduce HIV infections, particularly among women living in sub-Saharan Africa.
Authors: Christina Gosmann; Melis N Anahtar; Scott A Handley; Mara Farcasanu; Galeb Abu-Ali; Brittany A Bowman; Nikita Padavattan; Chandni Desai; Lindsay Droit; Amber Moodley; Mary Dong; Yuezhou Chen; Nasreen Ismail; Thumbi Ndung'u; Musie S Ghebremichael; Duane R Wesemann; Caroline Mitchell; Krista L Dong; Curtis Huttenhower; Bruce D Walker; Herbert W Virgin; Douglas S Kwon Journal: Immunity Date: 2017-01-10 Impact factor: 31.745
Authors: Christina Gosmann; Stephen R Mattarollo; Jennifer A Bridge; Ian H Frazer; Antje Blumenthal Journal: J Immunol Date: 2014-07-25 Impact factor: 5.422
Authors: Amie L Meditz; Michelle K Haas; Joy M Folkvord; Kelsey Melander; Russ Young; Martin McCarter; Samantha Mawhinney; Thomas B Campbell; Yolanda Lie; Eoin Coakley; David N Levy; Elizabeth Connick Journal: J Virol Date: 2011-08-03 Impact factor: 5.103
Authors: Hanneke Borgdorff; Evgeni Tsivtsivadze; Rita Verhelst; Massimo Marzorati; Suzanne Jurriaans; Gilles F Ndayisaba; Frank H Schuren; Janneke H H M van de Wijgert Journal: ISME J Date: 2014-03-06 Impact factor: 10.302
Authors: Jessica L Prodger; Ronald H Gray; Brett Shannon; Kamnoosh Shahabi; Xiangrong Kong; Kate Grabowski; Godfrey Kigozi; Fred Nalugoda; David Serwadda; Maria J Wawer; Steven J Reynolds; Cindy M Liu; Aaron A R Tobian; Rupert Kaul Journal: PLoS Pathog Date: 2016-11-29 Impact factor: 6.823
Authors: Steven S Witkin; Helena Mendes-Soares; Iara M Linhares; Aswathi Jayaram; William J Ledger; Larry J Forney Journal: mBio Date: 2013-08-06 Impact factor: 7.867
Authors: Alexander S Zevin; Irene Y Xie; Kenzie Birse; Kelly Arnold; Laura Romas; Garrett Westmacott; Richard M Novak; Stuart McCorrister; Lyle R McKinnon; Craig R Cohen; Romel Mackelprang; Jairam Lingappa; Doug A Lauffenburger; Nichole R Klatt; Adam D Burgener Journal: PLoS Pathog Date: 2016-09-22 Impact factor: 6.823
Authors: Michele N Austin; Leslie A Meyn; Hilary A Avolia; Melinda A Petrina; Lisa A Cosentino; Calins Alphonse; Beatrice A Chen; Katherine Bunge; Lisa Noguchi; Richard Beigi; Kathleen Squires; Sharon L Hillier Journal: J Infect Dis Date: 2022-06-15 Impact factor: 7.759
Authors: Maria Christine Krog; Mette Elkjær Madsen; Sofie Bliddal; Zahra Bashir; Laura Emilie Vexø; Dorthe Hartwell; Luisa W Hugerth; Emma Fransson; Marica Hamsten; Fredrik Boulund; Kristin Wannerberger; Lars Engstrand; Ina Schuppe-Koistinen; Henriette Svarre Nielsen Journal: Hum Reprod Open Date: 2022-03-23
Authors: Sharon L Achilles; Leslie A Meyn; Felix G Mhlanga; Allen T Matubu; Kevin A Stoner; May A Beamer; Zvavahera M Chirenje; Sharon L Hillier Journal: Am J Reprod Immunol Date: 2020-06-25 Impact factor: 3.886